aod9604 development discontinued π₯ What is AOD-9604? AOD stands for Advanced Obesity Drug, also known as AOD-9604. It's a fat-burning fragment of Human Growth Hormone (HGH,) specifically fragment 176β191, designed to deliver metabolic benefits without tested materials for laboratory and scientific research applications. AOD-9604 | Next Gen Peptides
Description
The amount of water you add determines the concentration and directly affects measurement accuracy

However, the largest 24-week trial with 536 participants failed to show statistically significant weight loss, which led to development termination

WADA Prohibition The World Anti-Doping Agency explicitly prohibits AOD-9604 for competitive athletes: Listed under Section S0 (Non-Approved Substances) and S2.2.3 (Growth Hormone Fragments) Prohibited at all times (both in-competition and out-of-competition) No Therapeutic Use Exemptions (TUEs) available Detection methods developed and implemented in anti-doping laboratories worldwide WADAs 2013 statement clarified that AOD-9604 is a substance still under pre-clinical and clinical development and has not been approved for therapeutic use by any government health authority in the world. Research Classification: AOD-9604 is available only for laboratory research use

Countless patients have relied on peptides like AOD 9604 for weight loss, with promising results

Weight-based dosing provides a more individualized approach than flat-dose recommendations
